Blog
RSS FeedPosted by Michael Wonder on 10 Apr 2025
Pfizer wins Korea nod for paediatric arthritis use of oral JAK inhibitor Xeljanz
7 April 2025 - Pfizer Korea has won national reimbursement for its oral JAK inhibitor Xeljanz (tofacitinib), expanding access to ...
Posted by Michael Wonder on 05 Apr 2025
Trump Administration rejects expanding Medicare, Medicaid coverage of obesity drugs
4 April 2025 - Biden Administration had proposed late last year coverage of the popular medicines for obesity. ...
Posted by Michael Wonder on 04 Apr 2025
Janssen Korea’s Zytiga secures expanded reimbursement for first-line prostate cancer treatment
2 April 2025 - Beginning in April, Janssen Korea's prostate cancer drug Zytiga will be available with prednisolone as a ...
Posted by Michael Wonder on 03 Apr 2025
GSK Korea's long-acting HIV injection therapy gains insurance benefit
1 April 2025 - GSK Korea said its long-acting injectable HIV-1 combination treatment, Vocabria (cabotegravir 600 mg) and Rekambys (rilpivirine ...
Posted by Michael Wonder on 02 Apr 2025
Sanofi launches new cholesterol lowering injection in Korea with health insurance coverage
1 April 2025 - Sanofi Korea announced the launch of Praluent Pen 300 mg (alirocumab) today following its inclusion in ...
Posted by Michael Wonder on 02 Apr 2025
Doctors push for weight loss drugs to be added to the PBS
1 April 2025 - The cost of prescriptions for weight loss drugs is being brought into question, with doctors pushing ...
Posted by Michael Wonder on 31 Mar 2025
PHARMAC proposing to fund two brands of oestradiol patches
27 March 2025 - PHARMAC is seeking feedback on a proposal to fund two brands of oestradiol patches for New ...
Posted by Michael Wonder on 27 Mar 2025
ViiV Healthcare announces reimbursement for Apretude for HIV-1 pre-exposure prophylaxis under the Non-Insured Health Benefits (NIHB) Program
25 March 2025 - ViiV Healthcare is pleased to announce that Apretude (cabotegravir tablets and extended release injectable suspension) is ...
Posted by Michael Wonder on 27 Mar 2025
New and expanded cheaper medicines
27 March 2025 - Australians with Cushing’s syndrome, retinal vein occlusion and psoriatic arthritis, leukaemia, and women needing contraception and menopause ...
Posted by Michael Wonder on 20 Mar 2025
Global pharma gives up reimbursement in Korea, and this is a serious concern
19 March 2025 - "We believe convincing our headquarters is no longer feasible, and we have no plans to apply ...
Posted by Michael Wonder on 17 Mar 2025
Government delivering even more choice for women's contraception, endometriosis, and IVF journeys
16 March 2025 - The Government is delivering even more choice for Australian women with new and amended listings for contraception, ...
Posted by Michael Wonder on 12 Mar 2025
PHARMAC to fund more cancer medicines (March 2025)
12 March 2025 - PHARMAC is funding six more medicines for cancers and one for antibiotic resistant infections. ...
Posted by Michael Wonder on 11 Mar 2025
PHARMAC funds new oral contraceptive pill
11 March 2025 - PHARMAC has decided to fund a new progestogen only oral contraceptive pill called desogestrel (Cerazette). ...
Posted by Michael Wonder on 10 Mar 2025
New insulin medicine proposed for people with diabetes
10 March 2025 - PHARMAC is seeking public feedback on a proposal to fund a new, additional type of insulin ...
Posted by Michael Wonder on 10 Mar 2025
Life changing new drug available for elderly Australians with devastating eye condition
9 March 2025 - A life changing new drug is now available on the PBS for elderly Australians with a ...